Le Lézard
Classified in: Health
Subjects: SVY, EXE, AVO, MAT

Truth Initiative: New report shows that Marlboro is one of the most influential brands among teenagers, raising significant concern on the proposed Marlboro branding of IQOS HeatSticks


WASHINGTON, Feb. 2, 2018 /PRNewswire-USNewswire/ -- Yesterday, the Centers for Disease Control and Prevention released a MMWR report, "Cigarette Brand Preference and Pro-Tobacco Advertising Among Middle and High School Students." The report explored the preferred cigarette brands among youth and the impact of advertising on their smoking behavior from 2012-2016. Not surprisingly, the report found that Marlboro tops the list of preferred cigarette brands among teenagers, followed by Newport and Camel. In 2016, 73 percent of middle school smokers and 79 percent of high school smokers used these brands. Importantly, the report found that this preference was strongly correlated with favorite advertisements ? with 72 percent of participants who identified a favorite advertisement, using the same brand they were exposed to in the ad.

Truth Initiative. (PRNewsFoto/Truth Initiative)

The powerful influence of advertising and brands, particularly the Marlboro brand, on young people reaffirms our deep concern that Philip Morris International's IQOS product, which would be marketed by Altria in the U.S., would also include the introduction of Marlboro-branded HeatSticks to the U.S. market. Our expectation is that the marketing efforts behind IQOS and HeatSticks in the U.S. will be significant, as the company spent more than $3 billion developing the product and implemented large-scale consumer marketing programs in countries such as Japan where IQOS and Marlboro-branded HeatSticks have already launched. Because of this and the known impact of advertising on brand preference, there is a real risk that there will be a "halo effect" from Marlboro-branded HeatSticks in terms of overall promotion of the Marlboro brand and therefore all Marlboro products (including combustible cigarettes). This is why we believe that any marketing approval from the FDA for IQOS must be clear in outlining marketing and advertising restrictions for Marlboro-branded HeatStick products.  Specifically, we believe that these products should have the same restrictions as cigarettes. Additionally, based on this data, we continue to support 21 as the minimum age for buying all tobacco products, including IQOS.

The tobacco industry spends $8 billion per year, or $1 million per hour on advertising. This is why public health campaigns, including federal campaigns and the award-winning truth® campaign, which is credited with preventing more than 300,000 U.S. youth and young adults from becoming smokers during 2015-2016, are critical in off-setting this. But these campaigns alone are not enough to counter the potential impact of the Marlboro brand. That is why we urge the FDA to regulate the marketing of Marlboro branding on the HeatStick products, and for states to revisit the minimum tobacco age.

About Truth Initiative
Truth Initiative is a national public health organization that is inspiring tobacco-free lives and building a culture where all youth and young adults reject tobacco. The truth about tobacco and the tobacco industry are at the heart of our proven-effective and nationally recognized truth public-education campaign, our rigorous and scientific research and policy studies, and our innovative community and youth engagement programs supporting populations at high risk of using tobacco. The Washington, D.C.-based organization, formerly known as Legacy, was established and funded through the 1998 Master Settlement Agreement between attorneys general from 46 states, five U.S. territories and the tobacco industry. To learn more about our work speaking, seeking and spreading the truth about tobacco, visit truthinitiative.org.

SOURCE Truth Initiative


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: